Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127534551 | 12753455 | 1 | I | 20160908 | 20160915 | 20160915 | EXP | PHFR2016GB007312 | SANDOZ | 0.00 | F | Y | 0.00000 | 20160915 | CN | COUNTRY NOT SPECIFIED | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127534551 | 12753455 | 1 | SS | BACLOFEN. | BACLOFEN | 1 | Unknown | 10 MG, QDS | 0 | 10 | MG | ||||||||
| 127534551 | 12753455 | 2 | PS | NITROFURANTOIN. | NITROFURANTOIN | 1 | Unknown | U | 74336 | ||||||||||
| 127534551 | 12753455 | 3 | C | COPAXONE | GLATIRAMER ACETATE | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 127534551 | 12753455 | 4 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | 1 G, QDS | U | 0 | 1 | G | |||||||
| 127534551 | 12753455 | 5 | C | PREGABALIN. | PREGABALIN | 1 | Unknown | 25 MG, BID | U | 0 | 25 | MG | BID | ||||||
| 127534551 | 12753455 | 6 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | 150 MG, QD | U | 0 | 150 | MG | QD | ||||||
| 127534551 | 12753455 | 7 | C | SOLIFENACIN | SOLIFENACIN | 1 | Unknown | UNK UNK, QD | U | 0 | QD | ||||||||
| 127534551 | 12753455 | 8 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | UNK UNK, QD | U | 0 | QD | ||||||||
| 127534551 | 12753455 | 9 | C | LITHIUM. | LITHIUM | 1 | Unknown | 1000 UG, QD | U | 0 | 1000 | UG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127534551 | 12753455 | 1 | Multiple sclerosis |
| 127534551 | 12753455 | 2 | Product used for unknown indication |
| 127534551 | 12753455 | 3 | Product used for unknown indication |
| 127534551 | 12753455 | 4 | Product used for unknown indication |
| 127534551 | 12753455 | 5 | Product used for unknown indication |
| 127534551 | 12753455 | 6 | Product used for unknown indication |
| 127534551 | 12753455 | 7 | Product used for unknown indication |
| 127534551 | 12753455 | 8 | Product used for unknown indication |
| 127534551 | 12753455 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127534551 | 12753455 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127534551 | 12753455 | Drug hypersensitivity | |
| 127534551 | 12753455 | Lower respiratory tract infection | |
| 127534551 | 12753455 | Multiple sclerosis relapse | |
| 127534551 | 12753455 | Muscle strain | |
| 127534551 | 12753455 | Sepsis | |
| 127534551 | 12753455 | Tremor | |
| 127534551 | 12753455 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |